Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NIDDK

Monoamine Oxidase Inhibitors

  • Read more about Monoamine Oxidase Inhibitors
US Application 60/484,710
Filed on 2003-07-03

Monoclonal Antibodies to HIV-1 VPR and Methods of Using Same

  • Read more about Monoclonal Antibodies to HIV-1 VPR and Methods of Using Same
US Application 60/585,282
Filed on 2004-07-01

Methods for Making and Using Mass Tag Standards for Quantitative Proteomics

  • Read more about Methods for Making and Using Mass Tag Standards for Quantitative Proteomics
US Application 60/574,612
Filed on 2004-05-25

A Novel Method For Protective Or Therapeutic Vaccination Of Animals And Humans Based On Induction Of T Cell Responses Via Dendritic Cell Cross-Priming With Self-Replicating Cytopathic And Noncytopathic RNA

  • Read more about A Novel Method For Protective Or Therapeutic Vaccination Of Animals And Humans Based On Induction Of T Cell Responses Via Dendritic Cell Cross-Priming With Self-Replicating Cytopathic And Noncytopathic RNA
US Application 60/463,097
Filed on 2003-04-14

Adenosine Derivatives As A3 Receptor Agonists

  • Read more about Adenosine Derivatives As A3 Receptor Agonists
US Application 60/482,459
Filed on 2003-06-26

USE OF PENTAGASTRIN TO INHIBIT GASTRIC ACID SECRETION OR AS A DIURETIC

  • Read more about USE OF PENTAGASTRIN TO INHIBIT GASTRIC ACID SECRETION OR AS A DIURETIC
US Application 60/156,491
Filed on 1999-09-28

Methods and Compositions to Detect Microbes In Fecal Samplesc

  • Read more about Methods and Compositions to Detect Microbes In Fecal Samplesc
US Application 60/468,341
Filed on 2003-05-06

Inducing a T-Cell Response With Recombinant Pestivirus Replicons or Recombinant Pestivirus Replicon-Transfected Dendritic Cells

  • Read more about Inducing a T-Cell Response With Recombinant Pestivirus Replicons or Recombinant Pestivirus Replicon-Transfected Dendritic Cells
US Application 60/462,165
Filed on 2003-04-11

Sigma-2 Receptor Agonists and Their Use in the Treatment of HIV Infection

  • Read more about Sigma-2 Receptor Agonists and Their Use in the Treatment of HIV Infection
US Application 60/440,367
Filed on 2003-01-16

Detection of Nucleic Acid Sequence Variations Using Phage Mu Transposase

  • Read more about Detection of Nucleic Acid Sequence Variations Using Phage Mu Transposase
US Application 60/457,934
Filed on 2003-03-28

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 24
  • Page 25
  • Page 26
  • Page 27
  • Page 28
  • Page 29
  • Page 30
  • Page 31
  • Page 32
  • …
  • Next page ››
  • Last page Last »
Subscribe to NIDDK
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health